ZimVie Inc., a leader in the dental implant market, is set to be delisted from the NASDAQ stock exchange following its acquisition by ARCHIMED. The transaction, valued at $19.00 per share in cash, is expected to close by the end of 2025, after which ZimVie will become a privately held company. The Board of Directors at ZimVie has unanimously approved the transaction, which is currently subject to approval by stockholders and regulatory bodies. In the interim, ZimVie is undertaking a "Go-Shop" period until August 29, 2025, to explore potential superior proposals with the assistance of Centerview Partners, although no developments are anticipated to be disclosed unless a superior proposal emerges.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ZimVie Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-161550), on July 21, 2025, and is solely responsible for the information contained therein.